FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Safecor Health Docusate Sodium 250 mg Recall

Docusate Sodium 250 mg, 1 Softgel in blister card-foils, 100-count unit dose box, www

Safecor Health, LLC · Woburn, MA

Risk level
Class II
Reported by FDA
Nov 27, 2024
Recall ID
D-0060-2025
Check your lot numberHow we source this data

Summary

Safecor Health recalled Docusate Sodium 250 mg starting Nov 11, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0060-2025 on Nov 27, 2024. Reason: cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity. Status: Ongoing.

Why it was recalled

cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.

Product description

Docusate Sodium 250 mg, 1 Softgel in blister card-foils, 100-count unit dose box, www.safecorhealth.com, NDC 48433-101-01

Lot numbers, UPCs & expiration codes

Lot# 34A0054, exp. date 05/07/2026

Where it was sold

USA nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0060-2025
Classification
Class II
Status
Ongoing
Recall initiated
Nov 11, 2024
FDA report date
Nov 27, 2024
Quantity
587 boxes
Recall type
Voluntary: Firm initiated
Recalling firm
Safecor Health, LLC

Original FDA data

Every field from FDA enforcement report D-0060-2025, exactly as published.

Show all FDA fields
City
Woburn
State
MA
Status
Ongoing
Country
United States
Event ID
95659
Address
317 New Boston St
Code information
Lot# 34A0054, exp. date 05/07/2026
Postal code
01801-6231
Report date
Nov 27, 2024
Product type
Drugs
Recall number
D-0060-2025
Classification
Class II
Recalling firm
Safecor Health, LLC
Product quantity
587 boxes
Reason for recall
cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Docusate Sodium 250 mg, 1 Softgel in blister card-foils, 100-count unit dose box, www.safecorhealth.com, NDC 48433-101-01
Distribution pattern
USA nationwide.
Recall initiation date
Nov 11, 2024
Initial firm notification
Letter
Center classification date
Nov 19, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0060-2025, published Nov 27, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls